Faster, better test for deadly fungus in vulnerable cancer patients
NCT ID NCT03349931
Summary
This study tested a new blood test kit designed to detect a dangerous fungal infection called invasive aspergillosis in patients with blood cancers. The test also checks if the fungus is resistant to common antifungal drugs. Researchers enrolled 350 adult patients at high risk for this infection to see how accurate the new test was compared to standard methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE ASPERGILLOSIS IN PATIENTS WITH ONCO-HAEMATOLOGICAL DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU de Lille, Hôpital Claude Huriez
Lille, 59000, France
-
CHU Bordeaux, Groupe hospitalier
Bordeaux, 33000, France
-
CHU de DIJON, Hôpital du bocage
Dijon, 21000, France
-
CHU de Nantes, Hôpital de Moncousu
Nantes, 44000, France
-
CHU de RENNES, hôpital de Pontchaillou
Rennes, 35000, France
-
Hôpital Necker - Enfants maladies (AP-HP)
Paris, Paris, 75015, France
Conditions
Explore the condition pages connected to this study.